CLINICAL ROLE -
Biologic Drug Receives FDA Approval for Eosinophilic Granulomatosis with Polyangiitis
A high number of patients with eosinophilic granulomatosis treated with mepolizumab achieve remission within 24 weeks compared with placebo patients.
Read More
Anti-Hypertensives May Increase the Risk of Skin Cancer
Patients taking hydrochlorothiazide may be 7 times more likely to develop squamous cell carcinoma.
New Blood Test May Detect Multiple Sclerosis Worsening
The presence of a nerve protein in the blood may indicate the development of new T1 and T2 lesions resulting from multiple sclerosis.
Research Outlines the Creation of Antibodies Against HIV Infection
These findings could lead to novel a HIV vaccine.
FDA Approves Short-Acting Follow-On Insulin
Ademlog (insulin lispro injection) approved to control blood glucose levels among patients with diabetes.
Trending News Today: Polypharmacy a Significant Concern to Seniors
Top news of the day from across the healthcare landscape.
Trending News Today: Lower Drug Costs May be the Key to Better Medication Adherence
Top news of the day from across the health care landscape.
Biologic Migraine Drug Gets FDA Review
Galcanezumab found to significantly decrease the average number of monthly migraine headache days.
Teva Announces Launch of Generic Viagra
Sildenafil tablets are a phosphodiesterase-5 inhibitor indicated for the treatment of erectile dysfunction.
American Diabetes Association Releases Annual Standards of Care
Updated diabetes treatment guidelines address the use of the medications with potential cardiovascular benefit.
Obesity Trends Indicate More Than Half of US Children at Risk
Obesity will be a significant problem for more than half of US children if current trends continue, according to a study published in the New England Journal of Medicine.
Understanding CMS Value-Based Payment Models to Advance Pharmacy Services
The outcomes-based reimbursement law passed in 2016, but providers are still struggling to understand what it means for the bottom line.
Vivitrol Is Making Its Way to Retail Pharmacies
This extended-release injectable suspension aims to prevent relapse in opioid-dependent patients after detox and treat alcoholism.
The 411 on Biohacking Supplements
Hacking the brain to work better and faster has been a hot topic, but research shows that nootropics products may fall short.
FDA Gives Final OK to First Short-Acting Follow-On Insulin for Diabetes
Officials with the FDA today approved insulin lispro injection (Admelog, Sanofi-Aventis US) 100 units/mL, the first short-acting insulin approved as a follow-on product.
CDC: US Influenza Activity on the Rise
Although activity remained low during October 2017, researchers reported an increase in influenza viruses since the beginning of November.
ADA Releases 2018 Standards of Care for Diabetes
The American Diabetes Association (ADA) has released their annual Standards of Medical Care in Diabetes for 2018, highlighting several updated recommendations for diabetes care and management.
PBM Acquisition Allows Diplomat Pharmacy Inc. to Expand Patient-Centric Offerings
Diplomat Pharmacy Inc.’s Acquisition of National Pharmaceutical Services will improve patient management services.
Digital Health Platforms May Not be a Cure All Solution
Online consultations may reduce the need for in-person appointments, but challenges can still arise.
Immunotherapy Combo Effective Against Rare Non-Hodgkin Lymphoma
Ibrutinib (Imbruvica) plus rituximab increased progression-free survival among patients with Waldenström's macroglobulinemia.
More Than Half of HIV Cases Diagnosed Late in Europe
Nearly 30,000 individuals were diagnosed with HIV in the European Region in 2016.
Trending News Today: Americans Face Price Increases, Few Options in ACA Marketplaces
Trending News Today: Drug Price Transparency Legislation in Jeopardy
Vaccinations Not Linked to Development of Multiple Sclerosis
A small number of multiple sclerosis cases following vaccinations affected compliance with vaccination recommendations.
Long-Acting COPD Treatment Gets FDA Approval
Glycopyrrolate inhalation solution is the first nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease.
Opioids Among Biggest Drug Safety Concerns of 2017
Institute for Safe Medication Practices releases annual review of the year’s biggest medication safety issues.
Generic Viagra Tablets Set to Launch
Teva Pharmaceutical Industries has announced the US launch of their generic sildenafil citrate (Viagra) tablets, according to a company press release.
Don't Be a Grinch: Celebrate with the Staff
Here are some fun ideas for celebrating this holiday season with the pharmacy crew.
The INFJ Pharmacist
Knowing your personality may assist you in practicing pharmacy with fulfillment.
The Top Medication Reminder Apps for Patients
Nonadherence impacts health outcomes, health care costs, and quality measures. Are mobile apps the way to increase adherence rates?